[Cite as http://purl.org/au-research/grants/nhmrc/1126304]
Brief description Chemotherapy is first-line treatment for advanced lung cancer patients. Most patients inevitably develop chemotherapy resistance. To increase chemotherapy effectiveness, we are developing a new antibody-based approach to target cancer cells that die because of chemotherapy. The antibody is armed with a very potent drug released specifically at the cancer to cause death of surrounding, chemotherapy-resistant cells. Killing these cells may reduce rebound cancer growth and cause an immune reaction.
Funding Amount $AUD 678,872.17
Funding Scheme Project Grants
New Investigator Grant